LTRN FY 2019 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena

LTRNLantern Pharma Inc.

$30M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1,627

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.39

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$117,760

Balance Sheet

Total Assets

$1M

Total Liabilities

$489,292

Stockholders' Equity

$943,284

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,627	$2,544	-164.0%
Operating Income	-$2M	-$2M	-40.6%
Net Income	-$2M	-$2M	-40.6%